SEC Comment Letter 0000000000-24-004809 to BIO-PATH HOLDINGS, INC. (BPTH)
BIO-PATH HOLDINGS, INC.
Date: April 30, 2024 · CIK: 0001133818 · Accession: 0000000000-24-004809
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278910
Letter
United States securities and exchange commission logo April 30, 2024 Peter Nielsen President and Chief Executive Officer Bio-Path Holdings, Inc. 4710 Bellaire Blvd, Suite 210 Bellaire, TX 77401 Re:Bio-Path Holdings, Inc. Registration Statement on Form S-1 Filed April 24, 2024 File No. 333-278910 Dear Peter Nielsen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: William R. Rohrlich, II, Esq.
Show Raw Text
United States securities and exchange commission logo
April 30, 2024
Peter Nielsen
President and Chief Executive Officer
Bio-Path Holdings, Inc.
4710 Bellaire Blvd, Suite 210
Bellaire, TX 77401
Re:Bio-Path Holdings, Inc.
Registration Statement on Form S-1
Filed April 24, 2024
File No. 333-278910
Dear Peter Nielsen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: William R. Rohrlich, II, Esq.